The Directorate of Revenue Intelligence (DRI) has busted an illegal laboratory manufacturing Alprazolam in Ghazipur, New Delhi, as part of its crackdown on the clandestine production of narcotic drugs and psychotropic substances.
According to the Ministry of Finance, DRI officers conducted an intelligence-led operation on November 15 and 16, 2026, and searched premises operating under the guise of a computer shop. The search revealed a fully functional clandestine laboratory equipped with reaction apparatus, a water chiller, a vacuum exhaust machine and other equipment used in the manufacturing process.
Editorial Insight
Key Highlights
Important points readers should notice.
DRI busted an illegal Alprazolam manufacturing laboratory in Ghazipur, New Delhi.
The premises was operating under the cover of a computer shop.
Approximately 148 kg of Alprazolam intermediate material was seized.
Around 1,046 kg of raw materials and chemicals were recovered.
Officials also seized 188 litres of additional chemicals and liquids.
One person operating the laboratory was arrested under the NDPS Act, 1985.
The operation resulted in the recovery of 148 kg of Alprazolam intermediate material in solid and liquid forms. Officials also seized approximately 1,046 kg of raw materials and chemicals, along with 188 litres of additional chemicals and liquids used in the manufacturing process.
The laboratory equipment and associated materials were seized under the provisions of the Narcotic Drugs and Psychotropic Substances (NDPS) Act, 1985. The person operating the clandestine laboratory was also arrested under the Act.
Alprazolam belongs to the benzodiazepine class of psychotropic substances and is a prescription medicine primarily used to treat anxiety and panic disorders. It is regulated under the NDPS Act, 1985, and its unauthorised manufacture, possession, sale and distribution attract legal penalties.
Editorial Analysis
Why This Matters
The discovery highlights the challenges posed by clandestine drug manufacturing facilities and the importance of enforcement operations to prevent the unauthorised production and distribution of regulated psychotropic substances.
The Ministry of Finance stated that the Delhi operation followed another major action by the DRI in Uttar Pradesh's Jalaun district on October 29, 2026. That operation resulted in the seizure of approximately 1,100 kg of drugs and precursor chemicals, along with manufacturing equipment, and the arrest of two people.
The latest operation highlights the DRI's intensified efforts to dismantle illegal drug manufacturing facilities, remove intermediate materials and precursor chemicals from illicit supply chains, and disrupt networks involved in unauthorised drug production.


